Impaired renal function further increases odds of 6-year coronary artery calcification progression in adults with type 1 diabetes: The CACTI study

Diabetes Care

Volumn 36, Issue 9, 2013, Pages 2607-2614

  Maahs, David M ^a,b   Jalal, Diana ^b   Chonchol, Michel ^b   Johnson, Richard J ^b   Rewers, Marian ^a   Snell Bergeon, Janet K ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYSTATIN C; HEMOGLOBIN A1C; TRIACYLGLYCEROL;

ADULT; ALBUMIN TO CREATININE RATIO; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; RENAL SYSTEM PARAMETERS; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

ADULT; ALBUMINS; CORONARY ARTERY DISEASE; CREATININE; DIABETES MELLITUS, TYPE 1; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84891806918     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-2538     Document Type: Article

References (39)

1. Maahs DM, Rewers M. Editorial: Mortality and renal disease in type 1 diabetes mellitusdprogress made, more to be done. J Clin Endocrinol Metab 2006;91: 3757-3759
2. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 1983;25: 496-501
3. Deckert T, Poulsen JE, Larsen M. Prognosis of diabetics with diabetes onset before the age of thirty-one. II. Factors influencing the prognosis. Diabetologia 1978;14: 371-377
4. Dorman JS, LaPorte RE, Kuller LH, et al. The Pittsburgh Insulin-dependent Diabetes Mellitus (IDDM) Morbidity and Mortality Study Mortality results. Diabetes 1984;33: 271-276
5. Groop PH, Thomas MC, Moran JL, et al. The presence and severity of chronic kidney disease predicts all-causemortality in type 1 diabetes. Diabetes 2009;58: 1651-1658
6. Orchard TJ, Secrest AM, Miller RG, Costacou T. In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 2010;53: 2312-2319
7. American Diabetes Association. Standards of medical care in diabetesd2010. Diabetes Care 2010;33(Suppl. 1):S11-S61
8. Maahs DM. Early detection of kidney disease in type 1 diabetes: what do we really know? Diabetes Technol Ther 2012; 14: 541-544
9. Maahs DM, Caramori ML, Cherney DZI, et al.; on behalf of the PERL Consortium. Uric acid lowering to prevent kidney function loss in diabetes: The Preventing Early Renal Function Loss (PERL) Allopurinol Study. Curr Diab Rep 2013;13: 550-559
10. Inker LA, Schmid CH, Tighiouart H, et al.; CKD-EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367: 20-29
11. Ninomiya T, Perkovic V, de Galan BE, et al.; ADVANCE Collaborative Group. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 2009;20: 1813-1821
12. Matsushita K, van der Velde M, Astor BC, et al.; Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-2081
13. Maahs DM, Kinney GL, Wadwa P, et al. Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population. Diabetes Care 2005;28: 301-306
14. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157: 2413-2446
15. Wadwa RP, Kinney GL, Maahs DM, et al. Awareness and treatment of dyslipidemia in young adults with type 1 diabetes. Diabetes Care 2005;28: 1051-1056
16. Maahs DM, Jalal D, McFann K, Rewers M, Snell-Bergeon JK. Systematic shifts in cystatin C between 2006 and 2010. Clin J Am Soc Nephrol 2011;6: 1952-1955
17. Snell-Bergeon JK, Hokanson JE, Jensen L, et al. Progression of coronary artery calcification in type 1 diabetes: the importance of glycemic control. Diabetes Care 2003;26: 2923-2928
18. Hokanson JE, MacKenzie T, Kinney G, et al. Evaluating changes in coronary artery calcium: an analytic method that accounts for interscan variability. AJR Am J Roentgenol 2004;182: 1327-1332
19. Jassal SK, Chonchol M, Laughlin GA, et al. Kidney function and progression of coronary artery calcium in community-dwelling older adults (from the Rancho Bernardo Study). Am J Cardiol 2012;110: 1425-1433
20. Maahs DM, Ogden LG, Kinney GL, et al. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 2005;111: 747-753
21. Jalal DI, Rivard CJ, Johnson RJ, et al. Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study. Nephrol Dial Transplant 2010;25: 1865-1869
22. Rodrigues TC, Maahs DM, Johnson RJ, et al. Serum uric acid predicts progression of subclinical coronary atherosclerosis in individuals without renal disease. Diabetes Care 2010;33: 2471-2473
23. Budoff MJ, Hokanson JE, Nasir K, et al. Progression of coronary artery calcium predicts all-cause mortality. JACC Cardiovasc Imaging 2010;3: 1229-1236
24. Peters SA, Bakker M, den Ruijter HM, Bots ML. Added value of CAC in risk stratification for cardiovascular events: a systematic review. Eur J Clin Invest 2012;42: 110-116
25. Nathan DM, Cleary PA, Backlund JY, et al.; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/ EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353: 2643-2653
26. Maahs DM, Ogden LG, Kretowski A, et al. Serum cystatin C predicts progression of subclinical coronary atherosclerosis in individuals with type 1 diabetes. Diabetes 2007;56: 2774-2779
27. Maahs DM, Snell-Bergeon JK, Kinney GL, et al. ACE-I/ARB treatment in type 1 diabetes patients with albuminuria is associated with lower odds of progression of coronary artery calcification. J Diabetes Complications 2007;21: 273-279
28. Livingstone SJ, Looker HC, Hothersall EJ, et al. Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Med 2012;9:e1001321
29. Miller ER 3rd, Juraschek S, Pastor- Barriuso R, Bazzano LA, Appel LJ, Guallar E. Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels. Am J Cardiol 2010; 106: 517-527
30. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005;352: 2049-2060
31. Perkins BA, Nelson RG, Krolewski AS. Cystatin C and the risk of death. N Engl J Med 2005;353:842-844; author reply 842-844
32. Perkins BA, Nelson RG, Ostrander BE, et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol 2005;16: 1404-1412
33. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney functiondmeasured and estimated glomerular filtration rate. N Engl J Med 2006;354: 2473-2483
34. Laing SP, Swerdlow AJ, Slater SD, et al. Mortality from heart disease in a cohort of 23, 000 patients with insulin-treated diabetes. Diabetologia 2003;46: 760-765
35. Colhoun HM, Rubens MB, Underwood SR, Fuller JH. The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification. J Am Coll Cardiol 2000;36: 2160-2167
36. Lloyd CE, Kuller LH, Ellis D, Becker DJ, Wing RR, Orchard TJ. Coronary artery disease in IDDM. Gender differences in risk factors but not risk. Arterioscler Thromb Vasc Biol 1996;16: 720-726
37. Costacou T, Fried L, Ellis D, Orchard TJ. Sex differences in the development of kidney disease in individuals with type 1 diabetes mellitus: a contemporary analysis. Am J Kidney Dis 2011;58: 565-573
38. Chase HP, Marshall G, Garg SK, Harris S, Osberg I. Borderline increases in albumin excretion rate and the relation to glycemic control in subjects with type I diabetes. Clin Chem 1991;37: 2048-2052
39. Cho YH, Craig ME, Hing S, et al. Microvascular complications assessment in adolescents with 2- to 5-yr duration of type 1 diabetes from 1990 to 2006. Pediatr Diabetes 2011;12: 682-689 Diseases